<DOC>
	<DOCNO>NCT01720108</DOCNO>
	<brief_summary>In study investigator want look whether use aspirin instead rivaroxaban ( initial treatment rivaroxaban ) work well prevent blood clot also reduce risk bleed cost effective patient either total hip replacement total knee replacement .</brief_summary>
	<brief_title>Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban Aspirin Following Total Hip Knee Arthroplasty</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Rivaroxaban</mesh_term>
	<criteria>1 . All patient undergo elective total hip knee arthroplasty participate institution potentially eligible study 1 . Hip low limb fracture previous three month 2 . Metastatic cancer 3 . Life expectancy le 6 month 4 . History major bleed judgment investigator precludes use anticoagulant prophylaxis 5 . History aspirin allergy , active peptic ulcer disease gastritis judgment investigator precludes use aspirin 6 . History significant hepatic disease condition judgement investigator precludes use rivaroxaban 7 . Creatinine clearance le 30 ml per minute 8 . Platelet count le 100 x 109 /L 9 . Need longterm anticoagulation due preexist comorbid condition due development venous thromboembolism follow surgery prior randomization 10 . Did receive rivaroxaban postoperatively VTE prophylaxis 11 . Bilateral total hip arthroplasty simultaneous hip knee arthroplasty 12 . Major surgical procedure within previous three month 13 . Requirement major surgery post arthroplasty within 90 day period 14 . Chronic daily aspirin use dose great 100 mg day 15 . Women child bear potential abstinent use appropriate contraception throughout study drug period 16 . Geographical inaccessibility followup 17 . Unwilling unable give consent 18 . Previous participation study 19 . Concomitant use drug strong inhibitor inducer Pgp CYP3A4</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>